Contents

Current Drug Targets - Infectious Disorders, Volume 2 - Number 2

Preface

, 2(2): i

Cele Abad-Zapatero


DOI: 10.2174/1568005023342614




Antibacterial Drug Discovery in the Post-Genomics Era

, 2(2): 109 - 119

Claude G. Lerner and Bruce A. Beutel


DOI: 10.2174/1568005023342597




The TB Structural Genomics Consortium: Providing a Structural Foundation for Drug Discovery

, 2(2): 121 - 141

Celia W. Goulding, Marcin Apostol, Daniel H. Anderson, Harindarpal S. Gill, Clare V. Smith, Mack R. Kuo, Jin KukYang, Geoffrey S. Waldo, Se Won Suh, Radha Chauhan, Avinash Kale, Nandita Bachhawat, Shekhar C. Mande, Jodie M. Johnston, J. Shaun Lott, Edward N. Baker, Vickery L. Arcus, David Leys, Kirsty J. McLean, Andrew W. Munro, Joel Berendzen, Vivek Sharma, Min S. Park, David Eisenberg, James Sacchettini, Tom Alber, Bernhard Rupp, William Jacobs, Jr. and Thomas C. Terwilliger


DOI: 10.2174/1568005023342551




Aminoglycoside Antibiotic Resistance by Enzymatic Deactivation

, 2(2): 143 - 160

Clyde A. Smith and Edward N. Baker


DOI: 10.2174/1568005023342533




Combating Infectious Diseases through Multivalent Design

, 2(2): 161 - 167

Erkang Fan and Ethan A Merritt


DOI: 10.2174/1568005023342588




Antibiotics Targeting Ribosomes: Crystallographic Studies

, 2(2): 169 - 186

Tamar Auerbach, Anat Bashan, Joerg Harms, Frank Schluenzen, Raz Zarivach, Heike Bartels, Ilana Agmon, Maggie Kessler, Marta Pioletti, Francois Franceschi and Ada Yonath


DOI: 10.2174/1568005023342506




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science